Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Conventional and Experimental Chemotherapy With Allogeneic Transplant in Young Patients With Acute Myeloid Leukaemia (AML)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01785953
Recruitment Status : Unknown
Verified February 2013 by Benedetto Bruno, Azienda Ospedaliera San Giovanni Battista.
Recruitment status was:  Recruiting
First Posted : February 7, 2013
Last Update Posted : February 7, 2013
Sponsor:
Information provided by (Responsible Party):
Benedetto Bruno, Azienda Ospedaliera San Giovanni Battista

Brief Summary:
The purpose of this study is evaluate patients with acute myeloid leukemia (<=66 years), treated with conventional and experimental chemotherapy following allogeneic transplantation. THis patients have been enrolled from 2000 to 2011 at the Division of Hematology, Molinette University Hospital. The purpose of data collection is to assess, with retrospective analysis, the clinical outcome divided by risk class and evaluated in patients who achieve complete remission after induction therapy and consolidation.

Condition or disease
Acute Myeloid Leukemia

Layout table for study information
Study Type : Observational
Estimated Enrollment : 300 participants
Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: CONVENTIONAL AND EXPERIMENTAL CHEMOTHERAPY WITH ALLOGENEIC TRANSPLANT IN YOUNG PATIENTS WITH ACUTE MYELOID LEUKAEMIA
Study Start Date : February 2013
Estimated Primary Completion Date : February 2014
Estimated Study Completion Date : February 2014


Group/Cohort
1



Primary Outcome Measures :
  1. Overall survival [ Time Frame: 1 year ]
  2. Event-free survival [ Time Frame: 1 year ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 66 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Acute myeloid leukemia patients
Criteria
Patients with acute myeloid leukemia (<=66 years), treated with conventional and experimental chemotherapy following allogeneic transplantation. THis patients have been enrolled from 2000 to 2011 at the Division of Hematology, Molinette University Hospital.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01785953


Contacts
Layout table for location contacts
Contact: Benedetto Bruno, MD +390116336728 benedetto.bruno@unito.it
Contact: Benedetto Bruno, MD +390116336728 gismm2001@yahoo.com

Locations
Layout table for location information
Italy
Città della Salute e della Scienza di Torino Recruiting
Torino, Italy, 10126
Contact: Benedetto Bruno, MD    +390116336728    benedetto.bruno@unito.it   
Sponsors and Collaborators
Azienda Ospedaliera San Giovanni Battista
Investigators
Layout table for investigator information
Principal Investigator: Benedetto Bruno, MD Divisione di Ematologia-Città della Salute e della Scienza di Torino

Layout table for additonal information
Responsible Party: Benedetto Bruno, MD, Azienda Ospedaliera San Giovanni Battista
ClinicalTrials.gov Identifier: NCT01785953     History of Changes
Other Study ID Numbers: AML-TO-2012
First Posted: February 7, 2013    Key Record Dates
Last Update Posted: February 7, 2013
Last Verified: February 2013
Additional relevant MeSH terms:
Layout table for MeSH terms
Leukemia
Leukemia, Myeloid
Leukemia, Myeloid, Acute
Neoplasms by Histologic Type
Neoplasms